Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

GoPro Inc (GPRO) Turning Heads Following Licensing Portal Launch: Do Hedge Funds Love GoPro?

Page 1 of 2

GoPro Inc (NASDAQ:GPRO) shares flew yesterday to a high that was over 8% above its closing price on Friday as the action camera maker announced its premium content licensing portal, a concrete step towwards the firm transforming itself into a media company. The stock closed yesterday up by 7.34%. While it has given back some of those gains in morning trading, down by 2.52% today, it is still up by nearly 5% since the announcement. According to GoPro Inc (NASDAQ:GPRO), the licensing portal is its next step in rewarding the GoPro creator community. Through the portal, global advertising brands and agencies will be given the chance to buy content made by GoPro users, and consequently, GoPro users will be compensated for their content. Analyst Charles Anderson of Dougherty & Co. is quoted writing in a note that he believes GoPro can build a licensing division that is similar in revenue size to Getty Images, which had about $900 million in revenue in 2014.


The confidence the market has in GoPro this week is reflected in the sentiment of hedge funds in the first quarter. It may appear to investors that a 10.79% quarter-over-quarter decline in the total value of holdings held by hedge funds we track who were long in GoPro Inc (NASDAQ:GPRO) on March 31 is a clearly bearish sign. However, taking the 31.34% fall of the stock’s price from January 2 to March 31 of this year into account, hedge funds actually bought more GoPro shares in the first quarter, possibly taking advantage of the reduced entry cost. They were not disappointed in the second quarter as the stock climbed by 21.45% from April 1 to June 30. Heading into the second quarter, a total of 25 of the hedge funds tracked by Insider Monkey were long in this stock, up by three from the end of the fourth quarter, a clear bullish sign. The held $284.33 million in GoPro shares as of March 31.

Why are we interested in the 13F filings of a select group of hedge funds? We use these filings to determine the top 15 small-cap stocks held by these elite funds based on 16 years of research that showed their top small-cap picks are much more profitable than both their large-cap stocks and the broader market as a whole. These small-cap stocks beat the S&P 500 Total Return Index by an average of nearly one percentage point per month in our backtests, which were conducted over the period of 1999 to 2012. Moreover, since the beginning of forward testing from August 2012, the strategy worked just as our research predicted, outperforming the market every year and returning 139.7% over the last 34 months, which is more than 80 percentage points higher than the returns of the S&P 500 ETF (SPY) (see more details).

An additional area Insider Monkey tracks is insider transactions as these trades can tell people whether certain key insiders of companies are betting on their stocks. For GoPro, there were no recorded purchases by insiders through July 20. The latest sale was by General Counsel Sharon Zezima who sold all of her shares by June 15. She sold a total of 6,000 shares on said date. Meanwhile President Anthony John Bates has sold a total of 225,170 shares in five transactions in June.

Considering all of this, we’re going to appraise the latest key hedge fund trades concerning GoPro Inc.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!